MARKET

STAA

STAA

STAAR Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

143.37
-0.79
-0.55%
After Hours: 147.72 +4.35 +3.03% 18:24 09/17 EDT
OPEN
145.86
PREV CLOSE
144.16
HIGH
145.99
LOW
141.52
VOLUME
676.39K
TURNOVER
--
52 WEEK HIGH
163.08
52 WEEK LOW
52.07
MARKET CAP
6.80B
P/E (TTM)
338.78
1D
5D
1M
3M
1Y
5Y
Insider Sell: Staar Surgical
MT Newswires · 17h ago
Staar Surgical Co (STAA) CFO Patrick F. Williams Sold $713,765 of Shares
GuruFocus News · 1d ago
Baillie Gifford Global Alpha Equities Fund Buys Epiroc AB, Carvana Co, Wayfair Inc, Sells ...
GuruFocus News · 4d ago
Insider Sell: STAAR Surgical
MT Newswires · 09/09 16:20
4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip
Zacks.com · 08/31 14:50
Cataract Surgery Devices Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2021-2027.
The global Cataract Surgery Devices market is expected to grow at a CAGR of 4.4% during the forecast period.The global Cataract Surgery Devices market is estimated to be about 6331.2 million US dollars in 2020.The global Cataract Surgery Devices market is ...
Heraldkeepers · 08/29 16:18
sam.gov Site Shows Co. Awarded Contract From Department Of Defense For Toric ICL Lenses
https://sam.gov/opp/9602c933b19546f38fb97b7bfd029915/view
Benzinga · 08/26 14:39
Why Staar Surgical (STAA) Might be Well Poised for a Surge
Zacks.com · 08/19 07:34
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of STAA. Analyze the recent business situations of STAAR Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average STAA stock price target is 147.00 with a high estimate of 165.00 and a low estimate of 120.00.
EPS
Institutional Holdings
Institutions: 372
Institutional Holdings: 51.16M
% Owned: 107.95%
Shares Outstanding: 47.40M
TypeInstitutionsShares
Increased
94
2.90M
New
73
1.07M
Decreased
90
3.40M
Sold Out
17
707.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Non-Executive Chairman/Independent Director
Louis Silverman
President/Chief Executive Officer/Director
Caren Mason
Chief Financial Officer
Patrick Williams
Senior Vice President
Hans-Martin Blickensdoerfer
Senior Vice President
James Francese
Senior Vice President
Graydon Hansen
Chief Technology Officer
Keith Holliday
Vice President
Jon Hayashida
Other
Scott Barnes
Secretary
Samuel Gesten
Independent Director
Stephen Farrell
Independent Director
Thomas Frinzi
Independent Director
Gilbert Kliman
Independent Director
Elizabeth Yeu
Independent Director
K. Peony Yu
No Data
About STAA
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29, 2017, the Company sold its products in over 75 countries, with distribution in the United States, Canada, Japan and Spain.

Webull offers kinds of STAAR Surgical Company stock information, including NASDAQ:STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.